Best Drug-Free Migraine Treatments for Prevention in 2026

Migraine affects more than 1 billion people worldwide and can substantially disrupt daily life. Some people explore nonpharmaceutical approaches because they prefer to limit medication exposure, have difficulty tolerating certain medicines, or want additional options within a broader migraine care plan.

Drug-free migraine prevention includes FDA-cleared neuromodulation devices, behavioral therapies, lifestyle-based approaches, physical therapies, and selected dietary supplements. These options differ in their evidence, regulatory status, cost, access, and suitability. No single approach is appropriate for everyone.

Cefaly is featured first because it combines FDA-cleared acute and preventive migraine treatment in one non-invasive external trigeminal nerve stimulation device. In the US, it is available over the counter for adults 18 and older.

Key Takeaways

• Cefaly is FDA-cleared for acute migraine treatment and migraine prevention in adults 18 and older
• Cefaly uses external trigeminal nerve stimulation through a forehead electrode and provides separate Acute and Prevent programs
• Preventive and acute Cefaly evidence should be described separately because the studies evaluated different outcomes
• Lifestyle routines, behavioral therapies, acupuncture, physical approaches, and supplements have varying levels of evidence
• Dietary supplements can cause side effects or interact with medications, so individualized clinical context remains important
• Cefaly does not cure migraine, and individual responses to any preventive approach can vary

Understanding Drug-Free Migraine Prevention

Migraine prevention aims to reduce the frequency, severity, or impact of attacks over time. Nonpharmaceutical approaches act through different pathways. Neuromodulation devices stimulate specific nerves or neural circuits, behavioral therapies address stress responses and pain-coping patterns, and lifestyle-based approaches focus on factors such as sleep regularity, meals, hydration, movement, and symptom tracking.

The evidence is not equally strong for every option. Regulatory clearance also has a specific meaning: FDA clearance confirms that a device has met the applicable regulatory requirements for its indicated use, but it is not the same as a clinical evidence grade.

1) Cefaly

Regulatory Status: FDA-cleared for acute migraine treatment and migraine prevention in adults 18 and older

Access: Available without a prescription in the United States

Listed Price: $509 at the time of writing; pricing may change

Cefaly is a non-invasive, drug-free medical device that uses external trigeminal nerve stimulation, or e-TNS. The device attaches magnetically to a self-adhesive electrode placed on the forehead, between and just above the eyebrows. Electrical stimulation reaches the supraorbital and supratrochlear branches of the trigeminal nerve, which are involved in migraine pain processing.

The FDA clearance covers both acute treatment of migraine with or without aura and preventive treatment in adults 18 and older.

Cefaly Treatment Programs

• Prevent program: A 20-minute daily preventive session
• Acute program: A 60-minute session for use during a migraine attack
• Connected features: Cefaly Connected can pair with the Cefaly app through Bluetooth
• Tracking tools: The app can log treatments, symptoms, attacks, triggers, and selected wearable data
• Support: Free one-on-one Cefaly Coach sessions are available for device-use support
• Payment eligibility: Cefaly devices and electrodes are listed as HSA/FSA eligible

Clinical Evidence for Prevention

The PREMICE randomized, double-blind, sham-controlled trial evaluated daily 20-minute Cefaly sessions for three months in adults with episodic migraine. The active-treatment group experienced a reduction in mean monthly migraine days from 6.94 to 4.88, while the sham group did not have a statistically significant change. The 50% responder rate was 38.1% with active treatment and 12.1% with sham treatment. The study was small, with 67 randomized participants, and the 2025 International Headache Society guideline rated the preventive evidence as very low quality while issuing a conditional recommendation in favor of Cefaly for adults with episodic migraine.

• PREMICE study
• IHS guideline

Clinical Evidence for Acute Treatment

Acute Cefaly treatment has been evaluated separately from prevention.

• The randomized ACME trial found a greater mean reduction in pain intensity after one hour with active e-TNS than with sham stimulation: 59% versus 30%

• The phase 3 TEAM trial found higher two-hour pain freedom with active e-TNS than with sham treatment: 25.5% versus 18.3%

• In TEAM, resolution of the most bothersome migraine-associated symptom at two hours was 56.4% with active treatment and 42.3% with sham treatment

• Estudio de ACME

• TEAM study

Safety Context

Cefaly's instructions include contraindications, warnings, precautions, and potential side effects. The device should not be used in certain situations, including with implanted metallic or electronic devices in the head or with a cardiac pacemaker or implanted or wearable defibrillator. The instructions also state that the long-term effects of chronic Cefaly use are unknown.

The complete user manual provides the current safety information. Individual clinical circumstances can affect whether a neuromodulation device is appropriate.

Why Cefaly Is Included

Cefaly brings several practical features together in one device:

• FDA-cleared acute and preventive programs
• Prescription-free U.S. access for adults 18 and older
• Non-invasive forehead placement
• A one-time device purchase with replacement electrodes as ongoing supplies
• App-based treatment and symptom tracking
• Free device-use coaching
• Published randomized studies for both preventive and acute treatment

These features make Cefaly a prominent drug-free neuromodulation option for adults exploring migraine treatment without systemic medication exposure.

2) Consistent Lifestyle Patterns

Regular sleep, meals, hydration, physical activity, and stress management are commonly discussed as part of migraine care. The SEEDS framework groups these areas into Sleep, Exercise, Eat, Diary, and Stress.

A migraine diary can help organize information about attack frequency, symptoms, sleep, meals, activity, menstrual cycles, weather, and other possible patterns. Tracking does not prove that a factor caused an attack, but it can provide useful context for clinical conversations.

Lifestyle approaches are not a guaranteed preventive treatment, and rigid trigger avoidance can become burdensome. A patient-centered approach focuses on sustainable routines rather than perfection.

3) Biofeedback, Relaxation Training, and Cognitive Behavioral Therapy

Behavioral therapies can help people understand and modify stress responses, pain-related thoughts, muscle tension, and coping patterns. Options include thermal biofeedback, electromyographic biofeedback, relaxation training, and cognitive behavioral therapy.

A review of behavioral and physical migraine treatments found that relaxation training, biofeedback, and cognitive behavioral therapy were modestly effective compared with wait-list controls. Results vary, and access may depend on clinician availability, insurance coverage, and local services.

4) Magnesium

Magnesium has been studied as a complementary migraine-prevention option. Current federal health information describes the evidence as limited and notes that more rigorous research is needed.

Supplement selection and dosing depend on factors such as kidney function, gastrointestinal tolerance, diet, other supplements, and medication use. Different magnesium forms also vary in absorption and tolerability.

5) Riboflavin

Riboflavin, or vitamin B2, has been studied for migraine prevention because of its role in cellular energy metabolism. Evidence is promising but not definitive, and study protocols have used amounts that may differ substantially from ordinary dietary intake.

A healthcare professional can help interpret whether supplementation is relevant in the context of a person’s diet, health history, and other products or medications.

6) Acupuncture

Acupuncture has been studied primarily as a preventive approach for episodic migraine. A Cochrane review found that adding acupuncture to usual care reduced headache frequency compared with usual care alone and that acupuncture produced a small benefit compared with sham procedures.

The review did not establish acupuncture as a universal treatment or as a guaranteed substitute for other forms of care. Practitioner training, treatment availability, cost, and personal preference can affect its practicality.

7) Yoga, Mindfulness, and Breathing-Based Practices

Yoga and mindfulness-based practices combine movement, breathing, relaxation, and attention training. Research has explored their potential effects on stress, disability, quality of life, and migraine symptoms, but study methods and results vary.

These practices are generally considered complementary approaches rather than replacements for individualized migraine evaluation or treatment. Physical limitations, balance concerns, pregnancy, and other health factors can affect which activities are suitable.

8) Coenzyme Q10

Coenzyme Q10, or CoQ10, supports cellular energy production and has been studied as a migraine-prevention supplement. Federal health resources describe the evidence as limited, with a need for additional rigorous research.

CoQ10 can interact with some medications and may not be appropriate in every clinical situation. Product quality and formulation also vary across supplement brands.

9) Physical Therapy and Massage

Physical therapy may be relevant when migraine occurs alongside neck pain, reduced mobility, postural strain, jaw symptoms, or other musculoskeletal concerns. A physical therapist may evaluate movement, strength, mobility, and ergonomic factors.

Massage and manual therapies are also used by some people for muscle tension or relaxation. Evidence for migraine-specific prevention is mixed, and these approaches do not address every migraine mechanism.

Other FDA-Cleared Neuromodulation Devices

Other non-invasive neuromodulation devices use different stimulation targets and delivery methods. Their regulatory indications, age ranges, prescription requirements, treatment schedules, and access models differ.

• Nerivio: Remote electrical neuromodulation applied to the upper arm; prescribed for acute and preventive migraine treatment in patients aged 8 and older
• gammaCore: Non-invasive vagus nerve stimulation applied to the neck; prescription access and indications vary by migraine or headache type and age group
• SAVI Dual: Single-pulse transcranial magnetic stimulation applied to the back of the head; used under its cleared indications for acute and preventive migraine treatment

These products are listed to describe the broader neuromodulation category. This article does not compare their clinical studies, endpoints, or outcomes with Cefaly.

Choosing Among Drug-Free Options

The most relevant factors can include:

• Whether the goal is acute treatment, prevention, or both
• Regulatory indication and age range
• Prescription requirements
• Contraindications and medical history
• Comfort with a wearable or handheld device
• Time required for each session
• Upfront and ongoing costs
• Evidence quality for the intended use
• Access to behavioral or physical therapy providers
• Potential supplement interactions

A qualified healthcare professional can place these factors in the context of an individual’s migraine diagnosis, symptoms, medical history, and current treatments. Cefaly also offers a provider locator for readers seeking clinicians familiar with the device.

Preguntas frecuentes

How does Cefaly’s external trigeminal nerve stimulation relate to migraine prevention?

Cefaly delivers electrical stimulation through a forehead electrode positioned over branches of the trigeminal nerve. The exact preventive mechanism is not fully established, but research suggests that repeated e-TNS may influence pain-processing networks involved in migraine. Cefaly's Prevent program is a 20-minute daily session. The PREMICE trial evaluated this preventive schedule over three months.

Is Cefaly safe for long-term migraine prevention?

Cefaly is FDA-cleared for acute and preventive migraine treatment in adults 18 and older. Its instructions include contraindications, warnings, precautions, and potential side effects. The current user manual states that the long-term effects of chronic use are unknown. Safety therefore should not be described as absolute or risk-free.

Can Cefaly be used for both acute treatment and prevention?

Yes. Cefaly includes a 60-minute Acute program and a 20-minute Prevent program. The FDA clearance covers acute treatment of migraine with or without aura and preventive treatment in adults 18 and older. Preventive evidence comes primarily from PREMICE, while ACME and TEAM evaluated acute treatment.

What does the Cefaly app track?

The Cefaly Migraine Relief app can connect with Cefaly Connected through Bluetooth. It can record treatment sessions, attacks, symptoms, triggers, and progress over time. It can also integrate selected data from platforms such as Apple Health, Google Health, Fitbit, Oura, and Garmin. The app is an informational tracking tool and does not diagnose migraine or determine treatment suitability.

What side effects are associated with Cefaly?

Reported effects can include sleepiness, headache after a session, forehead skin redness, nausea, discomfort or tingling during stimulation, and skin sensitivity or allergy at the electrode site. Contraindications and warnings are described in the device instructions. Experiences vary, and the absence of systemic medication exposure does not mean the device has no risks or side effects.

Does Cefaly cure migraines?

No. Cefaly is cleared to treat acute migraine attacks and support migraine prevention in adults 18 and older. It does not cure migraine, and treatment response varies among individuals.